Research On The Financial Support For Financial Leasing In The Biomedical Industry

Financing leases have been developed in China for nearly 40 years and have become an important source of financing for industries such as equipment manufacturing,shipping,transportation and energy.This new type of financial model effectively links industry and finance with the nature of its "financing+melting".The biomedicine is an important national pillar industry that has been vigorously developed in recent years in China.However,due to its high capital,high technology and long investment cycle,it is characterized by a single financing channel and a small amount of financing.At present,the penetration rate of financial leasing to the biomedical industry is around 10%,while the foreign penetration rate is 15%-30%,far exceeding China.In view of this,this paper discusses the positive significance of financial leasing to the development of the biomedical industry.Based on the in-depth analysis of the development of financial leasing and the status of bio-pharmaceutical financing,combined with the theory,the hypothesis and empirical analysis of the main factors affecting the decision-making of financial leasing of biomedical listed companies in China,the debt burden and profitability of biomedical companies are obtained.And operational capabilities affect their ability to make financial leases.Finally,based on the research results,the corresponding recommendations were made from the perspectives of biomedical companies,financial leasing companies and the government.